Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
The Oncologist|September 17, 2013
PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing?Jessica L Mester, Rebekah A Moore, Charis EngArzneimittel-Forschung|January 1, 1982
A new antagonist of the 5-hydroxytryptamine receptor of blood plateletsA Laubscher, A Pletscher, L Mester, et al.Acta Leprologica|July 1, 1986
[Treatment of leprosy by human metabolites]L Mester de Parajd, M Mester de ParajdHaemostasis|January 1, 1976
Effect of Amadori-type sugar derivatives of poly-L-lysine of platelet aggregationM Mester, B Kraska, J Crisba, et al.The Biochemical Journal|May 1, 1975
Accelerated uptake of 5-hydroxytryptamine by human blood platelets enriched in a sialic acidSzabados, L Mester, F Michal, et al.Urology|March 3, 2012
Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndromeJessica L Mester, Ming Zhou, Nichole Prescott, et al.Cleveland Clinic Journal of Medicine|August 3, 2012
Genetic counselors: your partners in clinical practiceJessica L Mester, Allison H Schreiber, Rocio T MoranGenetics in Medicine : Official Journal of the American College of Medical Genetics|January 21, 2012
Elevated plasma succinate in PTEN, SDHB, and SDHD mutation-positive individualsJudith A Hobert, Jessica L Mester, Jessica Moline, et al.Indian Journal of Leprosy|April 1, 1985
Mouse foot-pad studies with M. leprae--effect of desoxy fructo serotonin (DFS) and related compoundsS Balakrishnan, L Mester, H N Venkataramaniah, et al.Pageof 5